WMT

111.44

-0.41%↓

COST

861.88

-0.43%↓

TGT

97.78

+0.34%↑

KR

62.53

-0.24%↓

DG.US

132.74

-2.24%↓

WMT

111.44

-0.41%↓

COST

861.88

-0.43%↓

TGT

97.78

+0.34%↑

KR

62.53

-0.24%↓

DG.US

132.74

-2.24%↓

WMT

111.44

-0.41%↓

COST

861.88

-0.43%↓

TGT

97.78

+0.34%↑

KR

62.53

-0.24%↓

DG.US

132.74

-2.24%↓

WMT

111.44

-0.41%↓

COST

861.88

-0.43%↓

TGT

97.78

+0.34%↑

KR

62.53

-0.24%↓

DG.US

132.74

-2.24%↓

WMT

111.44

-0.41%↓

COST

861.88

-0.43%↓

TGT

97.78

+0.34%↑

KR

62.53

-0.24%↓

DG.US

132.74

-2.24%↓

Search

USANA Health Sciences Inc

Nyitva

19.53 -1.71

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

19.36

Maximum

19.58

Fő mutatók

By Trading Economics

Bevétel

-17M

-6.7M

Értékesítés

-22M

214M

P/E

Szektor átlag

21.922

28.154

Egy részvényre jutó nyereség

-0.15

Profit margin

-3.118

Munkavállalók

1,700

EBITDA

-17M

11M

Ajánlások

By TipRanks

Ajánlások

Semleges

12 hónapos előrejelzés

+98.68% upside

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

-21M

361M

Előző nyitás

21.24

Előző zárás

19.53

Technikai pontszám

By Trading Central

Bizalom

Weak Bullish Evidence

USANA Health Sciences Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2025. dec. 31. 22:20 UTC

Fő piaci mozgatók

Outlook Therapeutics Shares Fall After Another FDA Rejection of Macular Degeneration Drug

2025. dec. 31. 17:31 UTC

Fő piaci mozgatók

OwlTing Climbs on Launch of $10 Million Stock-Buyback Program

2025. dec. 31. 16:30 UTC

Fő piaci mozgatók

Trump Media Gains on Plan to Distribute Digital Tokens to Shareholders

2025. dec. 31. 15:19 UTC

Fő piaci mozgatók

Axsome Shares Climb on FDA Fast‑Track for Alzheimer's Drug, Backing for Narcolepsy Filing

2025. dec. 31. 15:17 UTC

Fő piaci mozgatók

Nike Shares Rise After CEO Hill Buys $1 Million of Shares

2025. dec. 31. 14:37 UTC

Fő piaci mozgatók

Corcept Shares Fall as FDA Requires More Evidence for Hypercortisolism Drug Application

2025. dec. 31. 21:50 UTC

Piaci beszéd

Basic Materials Roundup: Market Talk

2025. dec. 31. 21:13 UTC

Felvásárlások, összeolvadások, átvételek

10 People to Watch in Wealth Management in 2026 -- Barrons.com

2025. dec. 31. 20:40 UTC

Piaci beszéd

Dollar Posting Its Worst Year Since 2017 -- Market Talk

2025. dec. 31. 20:22 UTC

Piaci beszéd

Oil Posts Loss in a Year Marked By Plentiful Supply -- Market Talk

2025. dec. 31. 19:50 UTC

Piaci beszéd

U.S. Natural Gas Futures Sink on Weather Outlook -- Market Talk

2025. dec. 31. 19:31 UTC

Piaci beszéd

Precious Metals Cap Off Record Runs -- Market Talk

2025. dec. 31. 18:50 UTC

Piaci beszéd

Global Equities Roundup: Market Talk

2025. dec. 31. 18:50 UTC

Piaci beszéd

Canadian Gold Miners Enjoy a Bumper Year in 2025 -- Market Talk

2025. dec. 31. 17:17 UTC

Piaci beszéd

U.S. Natural Gas Inventories Fall Less Than Expected -- Market Talk

2025. dec. 31. 17:16 UTC

Fő piaci mozgatók

OwlTing Climbs on Launch of $10M Stock-Buyback Program

2025. dec. 31. 17:15 UTC

Piaci beszéd

Global Commodities Roundup: Market Talk

2025. dec. 31. 17:00 UTC

Felvásárlások, összeolvadások, átvételek

Nvidia Is Getting Creative as Options to Use Its Cash Flood Narrow -- Heard on the Street -- WSJ

2025. dec. 31. 15:57 UTC

Felvásárlások, összeolvadások, átvételek

Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval -- Barrons.com

2025. dec. 31. 15:54 UTC

Piaci beszéd

Layoff Data Supports Dollar at End of Losing Year -- Market Talk

2025. dec. 31. 15:02 UTC

Fő piaci mozgatók

Nike Shares Rise After CEO Hill Buys $1M of Shares

2025. dec. 31. 14:40 UTC

Felvásárlások, összeolvadások, átvételek

Nike CEO Buys $1 Million of Stock as Insiders Bet on a Turnaround -- Barrons.com

2025. dec. 31. 14:20 UTC

Piaci beszéd

Crude Futures On Track to End the Year With Losses -- Market Talk

2025. dec. 31. 13:46 UTC

Piaci beszéd

U.S. Natural Gas Falls on Milder Weather Outlook -- Market Talk

2025. dec. 31. 13:01 UTC

Eredményjelentés
Felvásárlások, összeolvadások, átvételek

Charles Schwab Is Back on Offense. Its Stock Is a Buy. -- Barrons.com

2025. dec. 31. 11:10 UTC

Piaci beszéd

Copper Remains in Touching Distance of Record Highs -- Market Talk

2025. dec. 31. 10:46 UTC

Piaci beszéd

Euro on Track For Strong Annual Performance -- Market Talk

2025. dec. 31. 10:25 UTC

Piaci beszéd

European Gas Prices Rise But Remain on Track for Heavy Annual Loss -- Market Talk

2025. dec. 31. 10:23 UTC

Piaci beszéd

Chinese Yuan Rises to 31-Month High Against Dollar as Policymakers -- Market Talk

2025. dec. 31. 09:33 UTC

Piaci beszéd

Dollar Set For Worst Annual Performance Since 2017 -- Market Talk

Társak összehasonlítása

Árváltozás

USANA Health Sciences Inc Előrejelzés

Célár

By TipRanks

98.68% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 39 USD  98.68%

Magas 39 USD

Alacsony 39 USD

1 Wall Street elemző 12 hónapos célárain alapulva a(z)USANA Health Sciences Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Semleges

1 ratings

0

Vétel

1

Tartás

0

Eladás

Technikai pontszám

By Trading Central

28.405 / 29.84Támogatás & ellenállás

Rövid táv

Weak Bullish Evidence

Középtáv

Bullish Evidence

Hosszú táv

No Evidence

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
help-icon Live chat